Market Overview:
The global hepatitis B testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of hepatitis B, rising awareness about hepatitis B and its diagnosis, and technological advancements in the field of diagnostics. The global hepatitis B testing market is segmented on the basis of type, application, and region. On the basis of type, it is divided into virus testing, antibody testing for HBsAg (hepatitis B surface antigen), and antibody testing for HBeAg (hepatitis Be antigen). On the basis of application, it is classified into hospitals and clinics. Geographically, it is analyzed across North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . Some key players operating in this market are Abbott Laboratories Inc., bioMérieux SA., F Hoffmann-La Roche Ltd., Siemens AG Healthcare Diagnostics Inc.
Product Definition:
Hepatitis B testing is a blood test that screens for the hepatitis B virus. It is used to diagnose hepatitis B infection, monitor the progress of treatment, and screen for liver damage. The importance of hepatitis B testing depends on your individual risk factors.
Virus:
Virus is a small particle of DNA or RNA that must enter the body in order to reproduce itself and cause disease. Viruses are not alive therefore cannot grow or multiply on their own. They must go into an animal or human cell and use the machinery of that cell in order to grow & multiply themselves outnumbering the amount of cells in the whole body.
For Antibodies:
For Antibodies is a blood test that measures the presence of an antibody response to Hepatitis B virus. The normal range for this test is 0.1-4.0 units/L with a standard deviation of 0.3 units/L, which makes it one of the most commonly performed blood tests across the globe and also in countries such as India, China, South Africa and Brazil where prevalence rates for hepatitis B are high (10% - 15%).
Application Insights:
Based on the application, the market is segmented into hospitals and clinics. Hospitals held the largest share of more than 60% in 2017 owing to availability of advanced healthcare facilities for hepatitis B testing across various regions. Moreover, rising prevalence of chronic conditions including liver diseases and cancer will drive demand from hospitals over the forecast period.
Clinics are expected to witness significant growth over the forecast period due to increasing awareness about preventable diseases among individuals at high-risk groups such as injecting drug users (IDUs), homosexuals, and people who have sex with men (MSM). For instance, according to a study published by CDC in September 2016, around 1 in 5 people aged 12 & above reported getting vaccinated against hepatitis B during 2015-2016 while around 1 in 10 adults aged 18 & above received vaccination during same time frame. These factors are expected to increase demand for effective vaccines resulting in higher adoption of diagnostic solutions which would propel industry growth over the coming years.
Regional Analysis:
North America dominated the global hepatitis B testing market in 2017. The presence of well-established healthcare infrastructure, high awareness levels coupled with relatively higher healthcare spending and prevalence of chronic diseases are some major factors responsible for its large share. In addition, increasing number of product launches by key companies is also expected to drive the growth during the forecast period. For instance, in May 2018 Gilead launched a new hepatitis B combination drug therapy that includes Harvoni and Sovaldi under brand name - Zepatier (sofosbuvir/ledipasvir).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising incidence rates as well as increasing prevalence of chronic diseases such as cancer & diabetes which are major risk factors for acquiring this infection. Moreover, improving economic conditions & growing health awareness among people will boost regional demand further during the estimated time span.
Growth Factors:
- Increasing incidence of hepatitis B infections across the globe
- Growing awareness about hepatitis B and its prevention measures
- Rising demand for early diagnosis and treatment of hepatitis B infections
- Technological advancements in diagnostic testing for hepatitis B infections
- Proliferation of private healthcare facilities and increasing number of patients seeking treatment for hepatitis B
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis B Testing Market Research Report
By Type
Virus, For Antibodies, For Antigens
By Application
Hospitals, Clinics
By Companies
Bio-Rad, AccuBioTech, Abbott, Alfa Scientific Designs, ALL.DIAG, Biogate Laboratories, Ameritek, Autobio Diagnostics, Hologic, Maccura Biotechnology, NanoEntek, Standard Diagnostics, Turklab Tibbi Malzemeler San, VEDA LAB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis B Testing Market Report Segments:
The global Hepatitis B Testing market is segmented on the basis of:
Types
Virus, For Antibodies, For Antigens
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bio-Rad
- AccuBioTech
- Abbott
- Alfa Scientific Designs
- ALL.DIAG
- Biogate Laboratories
- Ameritek
- Autobio Diagnostics
- Hologic
- Maccura Biotechnology
- NanoEntek
- Standard Diagnostics
- Turklab Tibbi Malzemeler San
- VEDA LAB
Highlights of The Hepatitis B Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Virus
- For Antibodies
- For Antigens
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis B Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hepatitis B testing is a blood test that can help diagnose the hepatitis B virus. The test can also help determine if someone has been exposed to the virus and whether they are at risk for developing hepatitis B.
Some of the key players operating in the hepatitis b testing market are Bio-Rad, AccuBioTech, Abbott, Alfa Scientific Designs, ALL.DIAG, Biogate Laboratories, Ameritek, Autobio Diagnostics, Hologic, Maccura Biotechnology, NanoEntek, Standard Diagnostics, Turklab Tibbi Malzemeler San, VEDA LAB.
The hepatitis b testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis B Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis B Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis B Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis B Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis B Testing Market Size & Forecast, 2018-2028
4.5.1 Hepatitis B Testing Market Size and Y-o-Y Growth
4.5.2 Hepatitis B Testing Market Absolute $ Opportunity
Chapter 5 Global Hepatitis B Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hepatitis B Testing Market Size Forecast by Type
5.2.1 Virus
5.2.2 For Antibodies
5.2.3 For Antigens
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hepatitis B Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hepatitis B Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis B Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis B Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hepatitis B Testing Analysis and Forecast
9.1 Introduction
9.2 North America Hepatitis B Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hepatitis B Testing Market Size Forecast by Type
9.6.1 Virus
9.6.2 For Antibodies
9.6.3 For Antigens
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hepatitis B Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hepatitis B Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Hepatitis B Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hepatitis B Testing Market Size Forecast by Type
10.6.1 Virus
10.6.2 For Antibodies
10.6.3 For Antigens
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hepatitis B Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hepatitis B Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hepatitis B Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hepatitis B Testing Market Size Forecast by Type
11.6.1 Virus
11.6.2 For Antibodies
11.6.3 For Antigens
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hepatitis B Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hepatitis B Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Hepatitis B Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hepatitis B Testing Market Size Forecast by Type
12.6.1 Virus
12.6.2 For Antibodies
12.6.3 For Antigens
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hepatitis B Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hepatitis B Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hepatitis B Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hepatitis B Testing Market Size Forecast by Type
13.6.1 Virus
13.6.2 For Antibodies
13.6.3 For Antigens
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hepatitis B Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis B Testing Market: Competitive Dashboard
14.2 Global Hepatitis B Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bio-Rad
14.3.2 AccuBioTech
14.3.3 Abbott
14.3.4 Alfa Scientific Designs
14.3.5 ALL.DIAG
14.3.6 Biogate Laboratories
14.3.7 Ameritek
14.3.8 Autobio Diagnostics
14.3.9 Hologic
14.3.10 Maccura Biotechnology
14.3.11 NanoEntek
14.3.12 Standard Diagnostics
14.3.13 Turklab Tibbi Malzemeler San
14.3.14 VEDA LAB
